Founders Office Hours: Bringing Deep Tech to Biotech with AION Labs, Amiti & AstraZeneca

​As part of Deep Tech Week, AION Labs and Amiti are proud to lead the biotech track, bringing together science, technology, and venture creation.

​Do you have an early-stage deep tech idea for biotech or pharma and want real, practical feedback from industry leaders?

​This exclusive session is your chance to pitch your idea directly to pharma, venture capital investors, and industry experts, and gain insights you won’t find anywhere else.

​Join us for an invite-only Office Hours session, where selected entrepreneurs will:

​•⁠  Receive direct feedback from AstraZeneca, Deep Tech investors, and techbio experts.

​•⁠  Get a reality check on the potential of your ideas in drug discovery and development.

​•⁠  Explore opportunities to spark collaborations - and maybe even secure investment.

​
👉 What do you need to do? Present a 15-minute pitch and get feedback from us. Spots are limited, so apply now and start your journey into deep tech for biotech.

​--

​About AION Labs

​AION Labs is a venture studio dedicated to building and investing in startups that leverage AI to revolutionize drug discovery and development. It is a unique partnership formed by AstraZeneca, Merck, Pfizer, Teva, the Israel Biotech Fund, Amiti Ventures, and AWS.

​About Amiti

​Amiti is an Israeli early-stage deep-tech fund. We invest with conviction, we have the best founding teams, those who are true magnets for talent, equipped with unique insight and the technical depth needed to deliver orders-of-magnitude advantage. We back founders tackling the hardest technological and scientific challenges in markets with near-insatiable demand. We invest and build when founding engineers and scientists envision a future and discover novel ways around limitations and obstacles.